国: ニュージーランド
言語: 英語
ソース: Medsafe (Medicines Safety Authority)
Glucose monohydrate 70%
Baxter Healthcare Ltd
Glucose monohydrate 70%
70 %
Solution for infusion
Active: Glucose monohydrate 70%
Bag, plastic, 500 mL
General sale
General sale
Baxter Healthcare Corporation
Hypertonic infusion solutions are indicated: - As a source of energy incorporated with parenteral nutrition with minimal dilution effect - For use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) The alimentary tract cannot or should not be used b) Gastrointestinal absorption of protein is impaired c) Metabolic requirements for protein are substantially increased, as with extensive burns.
Package - Contents - Shelf Life: Bag, plastic, - 500 mL - 24 months from date of manufacture stored at or below 30°C
1977-09-06
NEW ZEALAND DATA SHEET Glucose (Viaflex) Data Sheet 26 September 2019 Page 1 of 14 Baxter Healthcare Ltd 1 GLUCOSE INJECTION (BAXTER), (solution for infusion) GLUCOSE Injection (Baxter) 5% solution for infusion Glucose Injection (Baxter) 10% solution for infusion Glucose Injection (Baxter) 25% solution for infusion Glucose Injection (Baxter) 50% solution for infusion Glucose Injection (Baxter) 70% solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION _Active ingredient _ The active ingredient is glucose (monohydrate). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion. Glucose Injection (Baxter) are clear slightly coloured solutions for intravenous (IV) infusion, in a Viaflex® plastic bag. The Glucose Injection (Baxter) infusion preparations are sterile, non‐pyrogenic parenteral solutions. They do not contain an antimicrobial agent or added buffer, and have a pH of 3.5 ‐ 6.5 for 5% to 25% glucose concentrations, and a pH of 3.2 – 6.5 for 50% to 70% glucose concentrations. The concentrations of glucose dissolved in a litre of Water for Injections and their isotonicity are shown in Tables 1 and 2 (see section 6.5). The Glucose Injection (Baxter) 5% infusion is an _isotonic_ solution, whereas Glucose Injection (Baxter) 10% infusions are _hypertonic_. 4 CLINICAL PARTICULARS 4.1 Therapeutic indications Isotonic (Glucose Injection (Baxter) 5%) infusion solutions are mainly indicated: Whenever non‐electrolyte fluid replacement is required As a vehicle for drug delivery, provided that the added components are compatible with glucose. Hypertonic (Glucose Injection (Baxter) 10%) infusion solutions are indicated: As a source of energy incorporated with parenteral nutrition with minimal dilution effect For use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption 完全なドキュメントを読む